N,N'-[Sulfonylbis(1,4-phenylene)]bis(chloroacetamide)
N,N'-[Sulfonylbis(1,4-phenylene)]bis(chloroacetamide) Basic information
- Product Name:
- N,N'-[Sulfonylbis(1,4-phenylene)]bis(chloroacetamide)
- Synonyms:
-
- 4',4'''-Sulfonylbis(α-chloroacetanilide)
- Bis[4-(chloroacetylamino)phenyl] sulfone
- N,N'-[Sulfonylbis(1,4-phenylene)]bis(chloroacetamide)
- TC-E 5003
- N,N'-[Sulfonylbis(4,1-phenylene)]bis(2-chloroacetamide)
- TC-E 5003 (NSC-30176)
- 1-phenylene)bis(2-chloroacetamide)
- N'-(Sulfonyldi-4
- CAS:
- 17328-16-4
- MF:
- C16H14Cl2N2O4S
- MW:
- 401.26
- Mol File:
- 17328-16-4.mol
N,N'-[Sulfonylbis(1,4-phenylene)]bis(chloroacetamide) Chemical Properties
- Melting point:
- 191-192 °C
- Boiling point:
- 704.2±60.0 °C(Predicted)
- Density
- 1.504±0.06 g/cm3(Predicted)
- storage temp.
- -20°C (des.)
- solubility
- Soluble in DMSO (up to 50 mg/ml).
- pka
- 11.56±0.70(Predicted)
- form
- solid
- color
- Brown
- Stability:
- Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 1 month.
N,N'-[Sulfonylbis(1,4-phenylene)]bis(chloroacetamide) Usage And Synthesis
Description
TC-E 5003 is an inhibitor of protein arginine methyltransferase 1 (PRMT1; IC50 = 1.5 μM for human PRMT1 in a methylation assay). It is selective for PRMT1 over PRMT4/CARM1 and SET7/9 methyltransferases, with less than 5% inhibition at a concentration of 50 μM for SET7/9. TC-E 5003 inhibits growth of MCF-7a breast cancer and LNCaP prostate cancer cells (GI50s = 1.97 and 4.49 μM, respectively) and decreases androgen-dependent gene transcription in vitro. TC-E 5003 (80 mg/kg) also has antimalarial properties and eradicates P. berghei in mice.
Uses
NSC 30176 is a inhibitor of human PRMT1, it is selective for PRMT1 over the arginine methyltransferase CARM1 and the lysine methyltransferase Set7/9.
in vivo
TC-E 5003 (0.5-2.0 mg, s.c., a single dose for 28 days) has an excellent tumor-suppressing effect in A549 tumor xenograft ICR mouse models [3].
| Animal Model: | A549 tumor xenograft ICR mouse model[3] |
| Dosage: | 0.5-2.0 mg |
| Administration: | s.c., a single dose for 28 days |
| Result: | Achieved better antitumor effect in combination with INEI system in A549 tumor xenograft ICR mouse model. |
IC 50
PRMT1
References
[1] ELISABETH-MARIA BISSINGER . Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1[J]. Bioorganic & Medicinal Chemistry, 2011, 19 12: Pages 3717-3731. DOI:10.1016/j.bmc.2011.02.032
N,N'-[Sulfonylbis(1,4-phenylene)]bis(chloroacetamide)Supplier
- Tel
- 0731-85526065 13308475853
- ivy@hnhbsj.com
- Tel
- 400-6206333 13167063860
- anhua.mao@aladdin-e.com
- Tel
- 400-164-7117 13681763483
- product02@bidepharm.com
- Tel
- 025-66028182 18626450290
- yftan@aikonchem.com
- Tel
- 025-58849295 18951903616;
- info@adooq.cn